Mary Throndson
Psychiatric/Mental Health · Clinton, LANPI 1528411196
Payments from drug & device makers
Across 197 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$749
- AbbVie$481
- Otsuka America Pharmaceutical, Inc.$383
- Vanda Pharmaceuticals Inc.$247
- Axsome Therapeutics, Inc.$232
- Supernus Pharmaceuticals, Inc.$193
- plus $910 from 18 others
What the payments were for
- Food & beverage$3,194100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 58 | $749 |
| AbbVie(2 entities) | 38 | $481 |
| Otsuka America Pharmaceutical, Inc. | 21 | $383 |
| Vanda Pharmaceuticals Inc. | 10 | $247 |
| Axsome Therapeutics, Inc. | 9 | $232 |
| Supernus Pharmaceuticals, Inc. | 12 | $193 |
| Corium, LLC | 5 | $180 |
| Sunovion Pharmaceuticals Inc. | 9 | $119 |
| Alkermes, Inc. | 5 | $105 |
| Neurocrine Biosciences, Inc. | 3 | $71 |
| Ironshore Pharmaceuticals Inc. | 4 | $60 |
| Johnson & Johnson | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Tris Pharma Inc | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Novo Nordisk | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Lilly USA, LLC | 1 | $20 |
| Indivior Inc. | 1 | $17 |
| Medtronic | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Boehringer Ingelheim | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$105
How this compares
$3,194 in reported general payments places this provider in the 70th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 21 | $34,279 |
| VraylarCariprazine Hcl | 25 | $33,680 |
| RexultiBrexpiprazole | 18 | $24,805 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 28 | $5,274 |
| Lurasidone Hcl | 15 | $4,852 |
| VyvanseLisdexamfetamine Dimesylate | 13 | $4,221 |
| Aripiprazole | 44 | $4,115 |
| Trazodone Hcl | 135 | $1,468 |
| Hydroxyzine Pamoate | 59 | $1,146 |
| Clozapine | 18 | $1,076 |
| Bupropion XlBupropion Hcl | 74 | $980 |
| Duloxetine Hcl | 41 | $834 |
| Buspirone Hcl | 38 | $817 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $777 |
| Quetiapine Fumarate | 45 | $670 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $749 | $34,27921 claims |
| AbbVieVraylar | $481 | $33,68025 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $383 | $24,80518 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $33 | $4,22113 claims |
| Lilly USA, LLCOlanzapine | $20 | $23419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Clinton
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
- Lecy AlbaradoScott$34K
- Michelle DyerLake Charles$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.